Streptozotocin is equally diabetogenic whether administered to fed or fasted mice

Zunaira Z. Chaudhry, David L. Morris, Dan R. Moss, Emily K. Sims, Yien Chiong, Tatsuyoshi Kono, Carmella Evans-Molina

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Streptozotocin (STZ) is a selective pancreatic β cell toxin used to generate experimental hyperglycemia in rodent models. Several laboratory animal protocols suggest that STZ be administered to fasted rodents to minimize competition between STZ and glucose for low affinity GLUT2 transporters on β cells. However, whether the diabetogenic effects of multiple low dose (MLD)-STZ administration are enhanced by fasting has not been addressed. Given that repeated bouts of fasting can cause undue metabolic stress in mice, we compared the efficacy of MLD-STZ injections (50 mg/kg body weight daily for 5 days) to induce experimental hyperglycemia in both NOD/SCID/γchainnull and C57BL/6J mice that were either ad libitum fed (STZ-Fed) or that had been fasted for 6h (STZ-Fasted) prior to the time of STZ administration. Both STZ-Fed and STZ-Fasted mice had significantly worse glucose tolerance than vehicle-treated control mice 10 days after initiation of the MLD-STZ regimen. In C57BL/6J mice, fasting glucose levels, serum insulin levels, β cell mass, and glucose disposal during intraperitoneal glucose tolerance tests (IPGTTs) were indistinguishable between STZ-Fed and STZ-Fasted mice 20 days after MLD-STZ. The glucose intolerant phenotypes persisted for 20 weeks thereafter, irrespective of whether C57BL/6J mice were fed or fasted at the time of STZ injections. However, STZ-Fasted C57BL/6J mice experienced significant weight loss during the repeated bouts of fasting/ re-feeding that were required to complete the MLD-STZ protocol. In summary, induction of experimental hyperglycemia can be achieved using the MLD-STZ protocol without repeated bouts of fasting, which have the potential to cause metabolic stress in laboratory mice.

Original languageEnglish
Pages (from-to)257-265
Number of pages9
JournalLaboratory Animals
Volume47
Issue number4
DOIs
StatePublished - 2013

Fingerprint

streptozotocin
Streptozocin
mice
fasting
Fasting
Inbred C57BL Mouse
Glucose
hyperglycemia
dosage
Hyperglycemia
glucose
Physiological Stress
Rodentia
rodents
injection
glycemic effect
Injections
refeeding
Laboratory Animals
cells

Keywords

  • Animal protocol refinement
  • Diabetes
  • Fasting
  • Streptozotocin

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

Streptozotocin is equally diabetogenic whether administered to fed or fasted mice. / Chaudhry, Zunaira Z.; Morris, David L.; Moss, Dan R.; Sims, Emily K.; Chiong, Yien; Kono, Tatsuyoshi; Evans-Molina, Carmella.

In: Laboratory Animals, Vol. 47, No. 4, 2013, p. 257-265.

Research output: Contribution to journalArticle

Chaudhry, Zunaira Z. ; Morris, David L. ; Moss, Dan R. ; Sims, Emily K. ; Chiong, Yien ; Kono, Tatsuyoshi ; Evans-Molina, Carmella. / Streptozotocin is equally diabetogenic whether administered to fed or fasted mice. In: Laboratory Animals. 2013 ; Vol. 47, No. 4. pp. 257-265.
@article{de738ac42537421295de057088e99eb5,
title = "Streptozotocin is equally diabetogenic whether administered to fed or fasted mice",
abstract = "Streptozotocin (STZ) is a selective pancreatic β cell toxin used to generate experimental hyperglycemia in rodent models. Several laboratory animal protocols suggest that STZ be administered to fasted rodents to minimize competition between STZ and glucose for low affinity GLUT2 transporters on β cells. However, whether the diabetogenic effects of multiple low dose (MLD)-STZ administration are enhanced by fasting has not been addressed. Given that repeated bouts of fasting can cause undue metabolic stress in mice, we compared the efficacy of MLD-STZ injections (50 mg/kg body weight daily for 5 days) to induce experimental hyperglycemia in both NOD/SCID/γchainnull and C57BL/6J mice that were either ad libitum fed (STZ-Fed) or that had been fasted for 6h (STZ-Fasted) prior to the time of STZ administration. Both STZ-Fed and STZ-Fasted mice had significantly worse glucose tolerance than vehicle-treated control mice 10 days after initiation of the MLD-STZ regimen. In C57BL/6J mice, fasting glucose levels, serum insulin levels, β cell mass, and glucose disposal during intraperitoneal glucose tolerance tests (IPGTTs) were indistinguishable between STZ-Fed and STZ-Fasted mice 20 days after MLD-STZ. The glucose intolerant phenotypes persisted for 20 weeks thereafter, irrespective of whether C57BL/6J mice were fed or fasted at the time of STZ injections. However, STZ-Fasted C57BL/6J mice experienced significant weight loss during the repeated bouts of fasting/ re-feeding that were required to complete the MLD-STZ protocol. In summary, induction of experimental hyperglycemia can be achieved using the MLD-STZ protocol without repeated bouts of fasting, which have the potential to cause metabolic stress in laboratory mice.",
keywords = "Animal protocol refinement, Diabetes, Fasting, Streptozotocin",
author = "Chaudhry, {Zunaira Z.} and Morris, {David L.} and Moss, {Dan R.} and Sims, {Emily K.} and Yien Chiong and Tatsuyoshi Kono and Carmella Evans-Molina",
year = "2013",
doi = "10.1177/0023677213489548",
language = "English",
volume = "47",
pages = "257--265",
journal = "Laboratory Animals",
issn = "0023-6772",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Streptozotocin is equally diabetogenic whether administered to fed or fasted mice

AU - Chaudhry, Zunaira Z.

AU - Morris, David L.

AU - Moss, Dan R.

AU - Sims, Emily K.

AU - Chiong, Yien

AU - Kono, Tatsuyoshi

AU - Evans-Molina, Carmella

PY - 2013

Y1 - 2013

N2 - Streptozotocin (STZ) is a selective pancreatic β cell toxin used to generate experimental hyperglycemia in rodent models. Several laboratory animal protocols suggest that STZ be administered to fasted rodents to minimize competition between STZ and glucose for low affinity GLUT2 transporters on β cells. However, whether the diabetogenic effects of multiple low dose (MLD)-STZ administration are enhanced by fasting has not been addressed. Given that repeated bouts of fasting can cause undue metabolic stress in mice, we compared the efficacy of MLD-STZ injections (50 mg/kg body weight daily for 5 days) to induce experimental hyperglycemia in both NOD/SCID/γchainnull and C57BL/6J mice that were either ad libitum fed (STZ-Fed) or that had been fasted for 6h (STZ-Fasted) prior to the time of STZ administration. Both STZ-Fed and STZ-Fasted mice had significantly worse glucose tolerance than vehicle-treated control mice 10 days after initiation of the MLD-STZ regimen. In C57BL/6J mice, fasting glucose levels, serum insulin levels, β cell mass, and glucose disposal during intraperitoneal glucose tolerance tests (IPGTTs) were indistinguishable between STZ-Fed and STZ-Fasted mice 20 days after MLD-STZ. The glucose intolerant phenotypes persisted for 20 weeks thereafter, irrespective of whether C57BL/6J mice were fed or fasted at the time of STZ injections. However, STZ-Fasted C57BL/6J mice experienced significant weight loss during the repeated bouts of fasting/ re-feeding that were required to complete the MLD-STZ protocol. In summary, induction of experimental hyperglycemia can be achieved using the MLD-STZ protocol without repeated bouts of fasting, which have the potential to cause metabolic stress in laboratory mice.

AB - Streptozotocin (STZ) is a selective pancreatic β cell toxin used to generate experimental hyperglycemia in rodent models. Several laboratory animal protocols suggest that STZ be administered to fasted rodents to minimize competition between STZ and glucose for low affinity GLUT2 transporters on β cells. However, whether the diabetogenic effects of multiple low dose (MLD)-STZ administration are enhanced by fasting has not been addressed. Given that repeated bouts of fasting can cause undue metabolic stress in mice, we compared the efficacy of MLD-STZ injections (50 mg/kg body weight daily for 5 days) to induce experimental hyperglycemia in both NOD/SCID/γchainnull and C57BL/6J mice that were either ad libitum fed (STZ-Fed) or that had been fasted for 6h (STZ-Fasted) prior to the time of STZ administration. Both STZ-Fed and STZ-Fasted mice had significantly worse glucose tolerance than vehicle-treated control mice 10 days after initiation of the MLD-STZ regimen. In C57BL/6J mice, fasting glucose levels, serum insulin levels, β cell mass, and glucose disposal during intraperitoneal glucose tolerance tests (IPGTTs) were indistinguishable between STZ-Fed and STZ-Fasted mice 20 days after MLD-STZ. The glucose intolerant phenotypes persisted for 20 weeks thereafter, irrespective of whether C57BL/6J mice were fed or fasted at the time of STZ injections. However, STZ-Fasted C57BL/6J mice experienced significant weight loss during the repeated bouts of fasting/ re-feeding that were required to complete the MLD-STZ protocol. In summary, induction of experimental hyperglycemia can be achieved using the MLD-STZ protocol without repeated bouts of fasting, which have the potential to cause metabolic stress in laboratory mice.

KW - Animal protocol refinement

KW - Diabetes

KW - Fasting

KW - Streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=84890178550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890178550&partnerID=8YFLogxK

U2 - 10.1177/0023677213489548

DO - 10.1177/0023677213489548

M3 - Article

C2 - 23760565

AN - SCOPUS:84890178550

VL - 47

SP - 257

EP - 265

JO - Laboratory Animals

JF - Laboratory Animals

SN - 0023-6772

IS - 4

ER -